- Original Articles Hemato-oncology KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
- Sehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, Beomseok Suh, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
- Korean J Intern Med. 2017;32(3):514-522.
- Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
- Sehhoon Park, Seongyeol Park, Se-Hoon Lee, Beomseok Suh, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Young Whan Kim, Dae Seog Heo
- Korean J Intern Med. 2016;31(6):1140-1149.